Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Masuzu, UEDA"'
Autor:
Chihiro Yamamoto, Hirotomo Nakashima, Takashi Ikeda, Shin-ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Kiyomi Mashima, Takashi Nagayama, Kento Umino, Daisuke Minakata, Hirofumi Nakano, Kaoru Morita, Ryoko Yamasaki, Miyuki Sugimoto, Yuko Ishihara, Masahiro Ashizawa, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Shin-ichiro Fujiwara, Masuzu Ueda, Ken Ohmine, Kazuo Muroi, Yoshinobu Kanda
Publikováno v:
Blood Advances, Vol 3, Iss 21, Pp 3266-3277 (2019)
Abstract: The cost of tyrosine kinase inhibitors (TKIs) in the treatment of chronic myeloid leukemia (CML) is a substantial economic burden. In Japan, imatinib, dasatinib, and nilotinib are now approved as first-line treatment of CML in chronic phase
Externí odkaz:
https://doaj.org/article/457d89f637d1478bad0cfb53f35c1dde
Autor:
Chihiro Yamamoto, Daisuke Minakata, Daizo Yokoyama, Shuka Furuki, Atsuto Noguchi, Shunsuke Koyama, Takashi Oyama, Rui Murahashi, Hirotomo Nakashima, Takashi Ikeda, Shin-ichiro Kawaguchi, Kazuki Hyodo, Yumiko Toda, Shoko Ito, Takashi Nagayama, Kento Umino, Kaoru Morita, Masahiro Ashizawa, Masuzu Ueda, Kaoru Hatano, Kazuya Sato, Ken Ohmine, Shin-ichiro Fujiwara, Yoshinobu Kanda
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a8f5a7bffce7c70403932d02d28ff67
https://doi.org/10.2139/ssrn.4361264
https://doi.org/10.2139/ssrn.4361264
Autor:
Chihiro Yamamoto, Daisuke Minakata, Shunsuke Koyama, Kaoru Sekiguchi, Yuta Fukui, Rui Murahashi, Hirotomo Nakashima, Sae Matsuoka, Takashi Ikeda, Shin-ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Takashi Nagayama, Kento Umino, Hirofumi Nakano, Kaoru Morita, Ryoko Yamasaki, Masahiro Ashizawa, Masuzu Ueda, Kaoru Hatano, Kazuya Sato, Ken Ohmine, Shin-ichiro Fujiwara, Yoshinobu Kanda
Publikováno v:
Blood. 140(6)
Triplet regimens, such as lenalidomide, bortezomib, and dexamethasone (RVd) or thalidomide, bortezomib, and dexamethasone (VTd), are standard induction therapies for transplant-eligible patients with newly diagnosed multiple myeloma (NDMM). The addit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c86e9575fb206e8aad1d6a857afb2d26
https://pubmed.ncbi.nlm.nih.gov/35951343
https://pubmed.ncbi.nlm.nih.gov/35951343
Autor:
Kaoru Hatano, Shin-ichiro Fujiwara, Kento Umino, Takashi Ikeda, Hirofumi Nakano, Kiyomi Mashima, Shin-ichiro Kawaguchi, Shoko Ito, Yumiko Toda, Takashi Nagayama, Daisuke Minakata, Ryoko Yamasaki, Kaoru Morita, Chihiro Yamamoto, Masahiro Ashizawa, Kazuya Sato, Masuzu Ueda, Ken Ohmine, Yoshinobu Kanda
Publikováno v:
Annals of hematology. 101(6)
Aprepitant (Apr) is an effective antiemetic agent for chemotherapy-induced nausea and vomiting (CINV). Current CINV guidelines recommend the antiemetic combination of a 5-HT3 receptor antagonist, Apr, and dexamethasone (Dex) for highly emetogenic che
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a99b4a7c4fbb9906453457b84cd75b45
https://pubmed.ncbi.nlm.nih.gov/35403851
https://pubmed.ncbi.nlm.nih.gov/35403851
Autor:
Hirofumi Nakano, Takashi Ikeda, Kento Umino, Chihiro Yamamoto, Miyuki Sugimoto, Kazuya Sato, Iekuni Oh, Yuko Ishihara, Takashi Nagayama, Kaoru Hatano, Ryoko Yamasaki, Kazuo Muroi, Shoko Ito, Daisuke Minakata, Hirotomo Nakashima, Shin-Ichiro Kawaguchi, Shin-ichiro Fujiwara, Masuzu Ueda, Yoshinobu Kanda, Kaoru Morita, Masahiro Ashizawa, Ken Ohmine, Yumiko Toda, Kiyomi Mashima
Publikováno v:
Blood advances. 3(21)
The cost of tyrosine kinase inhibitors (TKIs) in the treatment of chronic myeloid leukemia (CML) is a substantial economic burden. In Japan, imatinib, dasatinib, and nilotinib are now approved as first-line treatment of CML in chronic phase. Recent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2623b7d8625aa734045fab2e55baa3a
https://pubmed.ncbi.nlm.nih.gov/31698458
https://pubmed.ncbi.nlm.nih.gov/31698458
Publikováno v:
European Journal of Haematology. 93:118-128
Objectives Increasing numbers of reports have described hematopoietic improvement after iron chelation therapy in iron-overloaded patients. These observations indicate that excess iron could affect hematopoiesis unfavorably. To investigate how excess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9b9ff82af3f5c0ffc0b9ac9a41d15f1
https://doi.org/10.1111/ejh.12309
https://doi.org/10.1111/ejh.12309
Autor:
Hiroshi Okabe, Chizuru Yamamoto, Ken Ohmine, Shin-ichiro Fujiwara, Masaki Mori, Iekuni Oh, Kazuo Muroi, Raine Tatara, Yuji Kikuchi, Eisuke Uehara, Rie Hosonuma, Tadashi Nagai, Kaoru Hatano, Yuji Hirata, Hiroyuki Kobayashi, Akiko Meguro, Katsutoshi Ozaki, Keiya Ozawa, Chihiro Yamamoto, Kazuya Sato, Tomohiro Matsuyama, Mitsuyo Uesawa, Masuzu Ueda, Masaki Toshima, Takahiro Suzuki, Akinori Nishikawa, Haruko Matsu, Miyuki Sasazaki
Publikováno v:
Leukemia & Lymphoma. 53:43-49
In the rituximab era, several large studies have suggested that full-dose rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) might be the best treatment for patients with diffuse large B-cell lymphoma (DLBCL) aged 60 ye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbf6e980b82127ec2e64787e68d0ef6a
https://doi.org/10.3109/10428194.2011.600486
https://doi.org/10.3109/10428194.2011.600486
Autor:
Satoko Oka, Masaki Mori, Shin-ichiro Fujiwara, Sato Kazuya, Tadashi Nagai, Iekuni Oh, Kazuo Muroi, Masaki Toshima, Masuzu Ueda, Satoru Kikuchi, Tomohiro Matsuyama, Katsutoshi Ozaki, Keiya Ozawa, Takahiro Suzuki
Publikováno v:
Leukemia & Lymphoma. 50:290-293
Chronic myelogeneous leukemia (CML) is characterised by a specific translocation t(9; 22)(q34; q11), the Philadelphia (Ph) chromosome, giving rise to the novel BCR/ABL fusion gene [1]. The deregula...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d1fb1e45246795d21b6d59f66beb068
https://doi.org/10.1080/10428190802627598
https://doi.org/10.1080/10428190802627598
Autor:
Iekuni Oho, Masuzu Ueda, Masaki Toshima, Katsutoshi Ozaki, Satoru Kikuchi, Takahiro Suzuki, Kazuo Muroi, Satoko Oka, Kazuya Sato, Tadashi Nagai, Masaki Mori, Shin-ichiro Fujiwara, Tomohiro Matsuyama, Keiya Ozawa
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 55:589-595
急性白血病では予防的血小板輸血が行われる．当院に入院した急性骨髄性白血病（AML）と急性リンパ性白血病（ALL）の血小板輸血トリガー（PT）値を検討した． 1994年から1999年のAMLとALL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::306f36f0a924216c08da2530f01245c9
https://doi.org/10.3925/jjtc.55.589
https://doi.org/10.3925/jjtc.55.589
Autor:
Satoko , Oka, Kazuo , Muroi, Kazuya , Sato, Chizuru , Yamamoto, Masuzu , Ueda, Yoko , Ono, Tomohiro , Matsuyama, Masaki , Toshima, Ken , Ohmine, Katsutoshi , Ozaki, Masaaki , Takatoku, Masaki , Mori, Tadashi , Nagai, Keiya , Ozawa
Publikováno v:
自治医科大学紀要 = Jichi Medical University Joumal. 30:173-180
Based on histological examinations of endoscopic biopsy specimens, gastrointestinal（ GI） tract B-cell lymphoma was diagnosed in 18 patients who had GI tract symptoms as their initial presentation. The affected sites were the stomach, small intest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::f1a5cc8104c186115db86b95013e9c85
http://id.nii.ac.jp/1561/00000666/
http://id.nii.ac.jp/1561/00000666/